NCT00942240View on ClinicalTrials.gov

Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy
Interventions
DRUG

ACU-4429

administered orally once a day for 14 days

DRUG

matching placebo tablet

administered orally once a day for 14 days

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc., Dallas

Sponsors

Lead Sponsor

Kubota Vision Inc.
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Kubota Vision Inc.

INDUSTRY